{
    "nctId": "NCT04247035",
    "briefTitle": "\u03a4reatment Standards and Outcomes of Patients With ER/PR Positive, HER2-negative Metastatic Breast Cancer",
    "officialTitle": "Non-Interventional, Multi-center Registry of Recording of Treatment Standards and Outcomes of Patients With ER/PR Positive, HER2-negative Metastatic Breast Cancer",
    "overallStatus": "UNKNOWN",
    "conditions": "Metastatic Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 300,
    "primaryOutcomeMeasure": "Evaluation of the outcome per treatment line",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Women with histological confirmed ER/PR positive, HER2-negative MBC\n* Age \\>18 years old\n* Patients initiating first or second line therapy for ER/PR positive, HER2-negative MBC\n* Adequate hematologic, renal and hepatic function\n* Signed informed consent (ICF)\n\nExclusion Criteria:\n\n* Active malignancy other than MBC\n* Active infection",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}